Real-time enrollment status for this kidney disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:47 PM UTC
| NCT Number | NCT05312879 |
| Recruiting Status | Recruiting |
| Condition | Kidney Disease |
| Phase | PHASE2 |
| Target Enrollment | 466 participants |
| Active Locations | 227 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 18, 2026: Clinical trial NCT05312879 is currently recruiting participants. This phase2 study for kidney disease is actively seeking new participants at 227 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05312879 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 227 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05312879 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.